Syneos Health (SYNH)
(Delayed Data from NSDQ)
$37.58 USD
-0.35 (-0.92%)
Updated Feb 6, 2023 04:00 PM ET
After-Market: $37.59 +0.01 (0.03%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Syneos Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | NA | 106 | 272 | 164 | 156 |
Receivables | NA | 1,525 | 1,345 | 1,304 | 1,257 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 135 | 121 | 95 | 79 |
Total Current Assets | NA | 1,766 | 1,738 | 1,562 | 1,492 |
Net Property & Equipment | NA | 223 | 216 | 204 | 183 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 35 | 35 | 37 | 9 |
Intangibles | NA | 5,810 | 5,710 | 5,323 | 5,467 |
Deposits & Other Assets | NA | 193 | 141 | 109 | 103 |
Total Assets | NA | 8,237 | 8,063 | 7,454 | 7,255 |
Liabilities & Shareholders Equity | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 108 | 114 | 137 | 99 |
Current Portion Long-Term Debt | NA | 0 | 0 | 58 | 50 |
Current Portion Capital Leases | NA | 21 | 17 | 18 | 14 |
Accrued Expenses | NA | 614 | 611 | 569 | 564 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 868 | 793 | 697 | 777 |
Total Current Liabilities | NA | 1,654 | 1,577 | 1,516 | 1,503 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 78 | 20 | 11 | 25 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2,776 | 2,902 | 2,550 | 2,737 |
Non-Current Capital Leases | NA | 34 | 32 | 37 | 27 |
Other Non-Current Liabilities | NA | 77 | 68 | 91 | 107 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 4,825 | 4,821 | 4,424 | 4,399 |
Shareholders Equity | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 3,474 | 3,462 | 3,441 | 3,403 |
Retained Earnings | NA | -13 | -180 | -341 | -459 |
Other Equity | NA | -50 | -41 | -72 | -88 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 3,413 | 3,242 | 3,030 | 2,856 |
Total Liabilities & Shareholder's Equity | NA | 8,237 | 8,063 | 7,454 | 7,255 |
Total Common Equity | 0 | 3,413 | 3,242 | 3,030 | 2,856 |
Shares Outstanding | 102.90 | 103.60 | 103.90 | 103.80 | 103.20 |
Book Value Per Share | 0.00 | 32.94 | 31.20 | 29.19 | 27.68 |
Fiscal Year End for Syneos Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | NA | 170 | 106 | 119 | 106 |
Receivables | NA | 1,647 | 1,607 | 1,596 | 1,525 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 146 | 169 | 161 | 135 |
Total Current Assets | NA | 1,963 | 1,882 | 1,876 | 1,766 |
Net Property & Equipment | NA | 256 | 255 | 240 | 223 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 31 | 34 | 35 | 35 |
Intangibles | NA | 5,561 | 5,657 | 5,752 | 5,810 |
Deposits & Other Assets | NA | 201 | 204 | 200 | 193 |
Total Assets | NA | 8,198 | 8,217 | 8,304 | 8,237 |
Liabilities & Shareholders Equity | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 119 | 99 | 108 | 108 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 25 | 24 | 22 | 21 |
Accrued Expenses | NA | 653 | 657 | 657 | 614 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 885 | 887 | 892 | 868 |
Total Current Liabilities | NA | 1,723 | 1,707 | 1,722 | 1,654 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 82 | 83 | 79 | 78 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2,752 | 2,812 | 2,906 | 2,776 |
Non-Current Capital Leases | NA | 50 | 49 | 40 | 34 |
Other Non-Current Liabilities | NA | 54 | 59 | 77 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 4,844 | 4,888 | 5,002 | 4,825 |
Shareholders Equity | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 3,449 | 3,426 | 3,411 | 3,474 |
Retained Earnings | NA | 112 | 25 | -53 | -13 |
Other Equity | NA | -209 | -123 | -57 | -50 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 3,354 | 3,329 | 3,302 | 3,413 |
Total Liabilities & Shareholder's Equity | NA | 8,198 | 8,217 | 8,304 | 8,237 |
Total Common Equity | 0 | 3,354 | 3,329 | 3,302 | 3,413 |
Shares Outstanding | 102.90 | 102.60 | 102.60 | 102.50 | 103.60 |
Book Value Per Share | 0.00 | 32.69 | 32.45 | 32.21 | 32.94 |